Disposition of [14C]-polystyrene microplastics after oral administration to lactating sheep

被引:0
|
作者
Shelver, Weilin L. [1 ]
McGarvey, Amy M. [1 ]
Billey, Lloyd O. [1 ]
机构
[1] US Agr Res Serv, Edward T Schafer Agr Res Ctr, USDA, Fargo, ND 58102 USA
基金
美国农业部;
关键词
Absorption; distribution; excretion; microplastics; polystyrene; sheep; GASTROINTESTINAL-TRACT; HEALTH-RISKS; PLASTICS; QUANTIFICATION; ACCUMULATION; INGESTION; PASSAGE; BIRDS; MILK; MEAL;
D O I
10.1080/19440049.2024.2379382
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Microplastics have become a ubiquitous contaminant, but their fate in food animals is largely unknown. In this study, [C-14]-polystyrene microplastic (PS-MP) particles were orally dosed to lactating sheep to evaluate their absorption and disposition. Elimination of the [C-14]-PS-MP was predominately through faeces with faecal radioactivity peaking at 24 h post-dosing but continuing to be present throughout the entire 72 h study period. Only a small fraction (<= 1%) of the dosed [C-14]-PS-MP was present in blood, milk, and urine. Pharmacokinetic analysis of blood plasma radioactivity, using non-compartment modeling, indicated rapid absorption (T-1/2 0.4 to 3 h) with slow elimination (T-1/2 37 to 48 h). Radioactivity in milk and urine had similar elimination patterns with radiocarbon activities peaking 24 h post-dosing with detectable elimination throughout the 72 h study period. No radioactivity was quantifiable in tissues at the 72 h withdrawal period.
引用
收藏
页码:1132 / 1143
页数:12
相关论文
共 50 条
  • [21] Biotransformation of [14C]-phenylbutazone after oral or intravenous administration to cattle.
    Smith, D
    Huwe, JK
    Lorentzsen, M
    Harrington, GE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U103 - U103
  • [22] Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects
    Nave, R
    Bethke, TD
    van Marle, SP
    Zech, K
    CLINICAL PHARMACOKINETICS, 2004, 43 (07) : 479 - 486
  • [23] A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors
    Liu, Yiqian
    Liu, Lianke
    Liu, Lingxiang
    Wang, Tongshan
    Guo, Lian
    Wang, Yixiang
    Gao, Zhengzhen
    Shu, Yongqian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 85 (05) : 907 - 915
  • [24] A phase I study investigation of metabolism, and disposition of [14C]-anlotinib after an oral administration in patients with advanced refractory solid tumors
    Yiqian Liu
    Lianke Liu
    Lingxiang Liu
    Tongshan Wang
    Lian Guo
    Yixiang Wang
    Zhengzhen Gao
    Yongqian Shu
    Cancer Chemotherapy and Pharmacology, 2020, 85 : 907 - 915
  • [25] DISPOSITION AND PHARMACOKINETICS OF [C-14] FINASTERIDE AFTER ORAL-ADMINISTRATION IN HUMANS
    CARLIN, JR
    HOGLUND, P
    ERIKSSON, LO
    CHRISTOFALO, P
    GREGOIRE, SL
    TAYLOR, AM
    ANDERSSON, KE
    DRUG METABOLISM AND DISPOSITION, 1992, 20 (02) : 148 - 155
  • [26] Identification of [14C]Fluasterone Metabolites in Urine and Feces Collected from Dogs after Subcutaneous and Oral Administration of [14C]Fluasterone
    Burgess, Jason P.
    Green, Jonathan S.
    Hill, Judith M.
    Zhan, Qiao
    Lindeblad, Matthew
    Lyubimov, Alexander
    Kapetanovic, Izet M.
    Schwartz, Arthur
    Thomas, Brian F.
    DRUG METABOLISM AND DISPOSITION, 2009, 37 (05) : 1089 - 1097
  • [27] Disposition of arsenobetaine in two marine fish species following administration of a single oral dose of [14C]arsenobetaine
    Amlund, Heidi
    Ingebrigtsen, Kristian
    Hylland, Ketil
    Ruus, Anders
    Eriksen, Dag Oistein
    Berntssen, Marc H. G.
    COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2006, 143 (02): : 171 - 178
  • [28] Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjects
    Peeters, PAM
    Van Lier, JJ
    Van De Merbel, N
    Oosterhuis, B
    Wieling, J
    Jonkman, JHG
    Klessing, K
    Biber, A
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1998, 23 (01) : 45 - 53
  • [29] Pharmacokinetics of [14C]-labelled losigamone and enantiomers after oral administration to healthy subjects
    P. A. M. Peeters
    J. J. Van Lier
    N. Van De Merbel
    B. Oosterhuis
    J. Wieling
    J. H. G. Jonkman
    K. Klessing
    A. Biber
    European Journal of Drug Metabolism and Pharmacokinetics, 1998, 23 : 45 - 53
  • [30] Disposition of [14C]-ranolazine in humans
    Chu, N
    Lustig, D
    Wong, S
    Jerling, M
    Zablocki, J
    Elzein, E
    Leung, KH
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49